Middle East News Dispatch
SEE OTHER BRANDS

The most trusted news from the Middle East

Middle East News Dispatch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Dispatch.

Press releases published on April 2, 2025

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …

Madhya Pradesh’s Rural Tourism Initiative Drives Sustainable Travel and Community Empowerment

Madhya Pradesh’s Rural Tourism Initiative Drives Sustainable Travel and Community Empowerment

Transforming 100 Villages into Cultural Hubs, Khari Exemplifies Success with 2,000+ Visitors in a Year BHOPAL, MADHYA PRADESH, INDIA, April 2, 2025 /⁨EINPresswire.com⁩/ -- Madhya Pradesh is strengthening its position as a top offbeat destination through …

BPX’s BIM Consulting Helps Construction Firms Improve Project Accuracy and Efficiency

BPX’s BIM Consulting Helps Construction Firms Improve Project Accuracy and Efficiency

Business Process Xperts (BPX) is a company that helps construction firms become more efficient by means of Building Information Modeling (BIM) consulting tools. PUNE, MAHARASHTRA, INDIA, April 2, 2025 /⁨EINPresswire.com⁩/ -- These services are directed to …

AGII Reinforces Blockchain Integrity with Real-Time AI Risk Detection

AGII Reinforces Blockchain Integrity with Real-Time AI Risk Detection

AGII expands its AI-powered security suite to deliver proactive, intelligent threat mitigation across decentralized ecosystems. SEATTLE, WA, UNITED STATES, April 2, 2025 /⁨EINPresswire.com⁩/ -- AGII, a leading innovator at the intersection of artificial …

NodeFoundry Secures Seed Investment from Angel syndicate and BlockchainVelocity to Advance Decentralized AI Compute

NodeFoundry Secures Seed Investment from Angel syndicate and BlockchainVelocity to Advance Decentralized AI Compute

Funding will accelerate launch of NodeFoundry’s DePIN-powered AI compute marketplace, designed to make decentralized infrastructure accessible and scalable UNITED ARAB EMIRATES, April 2, 2025 /⁨EINPresswire.com⁩/ -- NodeFoundry AI, a cutting-edge DePIN …

Nayax annonce l’acquisition d’Inepro Pay

Nayax annonce l’acquisition d’Inepro Pay

HERZLIYA, Israël, 02 avr. 2025 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq : NYAX ; TASE : NYAX), une plateforme d’envergure mondiale dédiée au développement du commerce et de paiement conçue pour aider les commerçants à développer leur activité en simplifiant …

Nayax gibt Übernahme von Inepro Pay bekannt

Nayax gibt Übernahme von Inepro Pay bekannt

HERZLIYA, Israel, April 02, 2025 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), eine globale Plattform für Handelsförderung und Zahlungen, die Händlern dabei helfen soll, ihr Geschäft durch die Vereinfachung von Zahlungen und die Maximierung …

"إكس أس دوت كوم" تواصل نجاحها وتشارك في معرض المكسيك بصفتها الراعي المميز

"إكس أس دوت كوم" تواصل نجاحها وتشارك في معرض المكسيك بصفتها الراعي المميز

UNITED ARAB EMIRATES, April 2, 2025 /⁨Business News⁩/ -- أعلنت مجموعة إكس أس العالمية "إكس أس دوت كوم" (XS.com)، الوسيط العالمي الرائد في مجال الخدمات المالية وتكنولوجيا أسواق المال، عن رعايتها لمعرض "أي أف إكس – لاتام - المكسيك" (IFX LATAM - Mexico)، …

AssistRx Completes Asset Acquisition from AllazoHealth, Strengthening its Advanced Tech + Talent Patient Support Services

AssistRx Completes Asset Acquisition from AllazoHealth, Strengthening its Advanced Tech + Talent Patient Support Services

ORLANDO, Fla., April 02, 2025 (GLOBE NEWSWIRE) -- AssistRx, the advanced therapy initiation and patient solutions provider, today announced it has completed an asset acquisition from AllazoHealth, a healthcare technology company driving therapy initiation, …

Polyrizon Engages Leading Branding Firm for Strategic Brand Development

Polyrizon Engages Leading Branding Firm for Strategic Brand Development

Raanana, Israel, April 02, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ), a biotech company specializing in innovative intranasal hydrogels, today announced that it has entered into an agreement with a globally recognized branding and trademark …

Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference

Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference

IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend the 24th Annual Needham …

Robex Progresses Kiniero Toward First Gold in Q4 2025

Robex Progresses Kiniero Toward First Gold in Q4 2025

 Highlights: Construction at Robex’s Kiniero Gold Project, Guinea, remains on schedule and budget - first gold pour on track for Q4 CY25. Project remains LTI free (lost time injury). Grade control drilling phase 1 contract awarded; drilling has commenced. …

Latin Metals Appoints Vice President Investor Relations

Latin Metals Appoints Vice President Investor Relations

VANCOUVER, British Columbia, April 02, 2025 (GLOBE NEWSWIRE) -- Latin Metals Inc. ("Latin Metals" or the "Company") - (TSXV: LMS) (OTCQB: LMSQF) is pleased to announce the appointment of Elyssia Patterson as Vice President, Investor Relations, effective …

CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that …

Infinidat Earns 5-Star Rating in the 2025 CRN® Partner Program Guide for the Fourth Consecutive Year

Infinidat Earns 5-Star Rating in the 2025 CRN® Partner Program Guide for the Fourth Consecutive Year

WALTHAM, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Infinidat, a leading provider of enterprise storage solutions, today announced that the company has been recognized by CRN®, a brand of The Channel Company, with a 5-Star Award in the 2025 CRN Partner …

Odysight.ai to participate at MRO Americas 2025 - International trade fair in the Aerospace Industry

Odysight.ai to participate at MRO Americas 2025 - International trade fair in the Aerospace Industry

Omer, Israel, April 02, 2025 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (Nasdaq: ODYS), a pioneering developer of AI systems for Predictive Maintenance (PdM) and Condition-Based Monitoring (CBM), today announced its participation in MRO Americas 2025, which will …

Fast Track to AV1 with Beamr: High-Quality at a Fraction of the Cost

Fast Track to AV1 with Beamr: High-Quality at a Fraction of the Cost

Beamr will showcase its high-performance AV1 solutions, accelerated by NVIDIA GPUs, and with simple, competitive pricing, at the 2025 NAB Show in Las Vegas HERZLIYA, Israel, April 02, 2025 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ: BMR), a leader in …

Atsena Therapeutics Announces Oversubscribed $150 Million Series C Financing to Further Advance Ocular Gene Therapy Programs

Atsena Therapeutics Announces Oversubscribed $150 Million Series C Financing to Further Advance Ocular Gene Therapy Programs

Financing led by new investor Bain Capital with participation from new investor Wellington Management and all existing investors Proceeds to support advancement of ATSN-201 through potential approval and launch as well as preclinical programs to treat …

Quoin Pharmaceuticals Announces Additional Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient

Quoin Pharmaceuticals Announces Additional Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient

Continued Clear Visual Evidence of Almost Completely Healed Skin After 6 weeks Treatment High Durability of Treatment Effect of QRX003 with Continuous Daily Dosing Patient Continues Not to Require Previously Necessary Medications With Patient’s Pruritus …

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that John Celebi, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service